Smith & Nephew Plc Director/PDMR Shareholding (0058Z)

TIDMSN.

RNS Number : 0058Z

Smith & Nephew Plc

19 January 2022

SMITH & NEPHEW PLC

19 January 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 18 January 2022, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------ 
 Details of the transaction(s): section to be repeated for (i) 
  each type of instrument; (ii) each type of transaction; (iii) 
  each date; and (iv) each place where transactions have been conducted 
 Description of the          Smith & Nephew plc SPON ADR American Depositary 
  financial instrument,       Shares (ADS) 
  type of instrument 
                            ------------------------------------------------ 
 Identification code         ISIN: US83175M2052 
                            ------------------------------------------------ 
 Nature of the transaction   Purchase of American Depository Shares as 
                              participants of the Company's Employee Stock 
                              Purchase Plan 
                            ------------------------------------------------ 
 Date of Transaction         2022 - 01 - 13 
                            ------------------------------------------------ 
 Place of Transaction        New York Stock Exchange 
                            ------------------------------------------------ 
 
 
                                                                                  Total Ordinary 
                                                                                   Share Holding 
                                                               Total Ordinary      as a % of 
                                                                Share Holding      the Company's 
                                                                following          ISC following 
 Name           Director    Price               Aggregated      the transaction    the transaction 
  (Position)     / PDMR      ($)    Volume       information    *                  * 
 Bradley 
  Cannon 
  (President                                                   78,530.17832 
  Sports                                                        (including 
  Medicine                                      N/A Single      2,718.50860 
  & ENT)        PDMR        29.43   284.93272    Transaction    in ADS')          0.00887% 
               ----------  ------  ----------  -------------  -----------------  ----------------- 
 Alison 
  Parkes                                                       1,538.24834 
  (Chief                                                        (including 
  Compliance                                    N/A Single      400.24362 
  Officer)      PDMR        29.43   220.86307    Transaction    in ADS')          0.00017% 
               ----------  ------  ----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSRLAIALIF

(END) Dow Jones Newswires

January 19, 2022 12:00 ET (17:00 GMT)